Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 1
2009 1
2010 1
2012 2
2013 1
2014 3
2016 2
2017 2
2018 3
2019 3
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Dasatinib reduces myelofibrosis by modulating pSTAT5 and NF-κB.
Schelker RC, Andrulis M, Müller G, Ushmorov A, Hart C, Herr W, Vogelhuber M, Iberl S, Grassinger J. Schelker RC, et al. Among authors: ushmorov a. Blood Cells Mol Dis. 2019 May;76:78-81. doi: 10.1016/j.bcmd.2019.02.005. Epub 2019 Feb 20. Blood Cells Mol Dis. 2019. PMID: 30827761 No abstract available.
FOXO in B-cell lymphopoiesis and B cell neoplasia.
Ushmorov A, Wirth T. Ushmorov A, et al. Semin Cancer Biol. 2018 Jun;50:132-141. doi: 10.1016/j.semcancer.2017.07.008. Epub 2017 Jul 31. Semin Cancer Biol. 2018. PMID: 28774833 Review.
Targeting the intratumor heterogeneity in PMBL.
Ritz O, Möller P, Ushmorov A. Ritz O, et al. Among authors: ushmorov a. Cell Cycle. 2014;13(15):2317-8. doi: 10.4161/cc.29828. Cell Cycle. 2014. PMID: 25483178 Free PMC article. No abstract available.
Adenosine receptor 2B activity promotes autonomous growth, migration as well as vascularization of head and neck squamous cell carcinoma cells.
Wilkat M, Bast H, Drees R, Dünser J, Mahr A, Azoitei N, Marienfeld R, Frank F, Brhel M, Ushmorov A, Greve J, Goldberg-Bockhorn E, Theodoraki MN, Doescher J, Laban S, Schuler PJ, Hoffmann TK, Brunner C. Wilkat M, et al. Among authors: ushmorov a. Int J Cancer. 2020 Jul 1;147(1):202-217. doi: 10.1002/ijc.32835. Epub 2020 Jan 9. Int J Cancer. 2020. PMID: 31846065
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page